In today’s highly competitive and increasingly regulated pharmaceutical industry, a company’s success can depend largely on the strength of its Sample Chain Management (SCM) system. For example, the ability to both measure and automatically adjust an organization’s sales and marketing strategy at the individual physician level based on his/her specific “cost per script written” is no longer an optional feature to an SCM system. This is true for both a growing organization whose entire future hinges on its ability to successfully deploy a small product portfolio, as well as a more mature organization launching a new product into previously untested territories.